HomeAbbVie’s $8.7 billion bet on Cerevel is risky but smart, analysts sayFILE PHOTO: A sign stands outside a Abbvie facility in

FILE PHOTO: A sign stands outside a Abbvie facility in

FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo

Most Read

Tesla gains on report Trump’s team planning federal self-driving vehicle regulations

November 18, 2024

Trump search for Treasury pick widens, sources say

November 18, 2024

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

November 15, 2024

Palantir shares rally to fresh record on plans for move to Nasdaq

November 15, 2024